Accelerate Diagnostics Inc
NASDAQ:AXDX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.7365
6.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc
Current Portion of Long-Term Debt
Accelerate Diagnostics Inc
Current Portion of Long-Term Debt Peer Comparison
BDX
BSX
SYK
ABT
ISRG
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Accelerate Diagnostics Inc
NASDAQ:AXDX
|
Current Portion of Long-Term Debt
$251k
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
10%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Current Portion of Long-Term Debt
$1.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
19%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Current Portion of Long-Term Debt
$1.6B
|
CAGR 3-Years
82%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
87%
|
|
|
Stryker Corp
NYSE:SYK
|
Current Portion of Long-Term Debt
$2.1B
|
CAGR 3-Years
604%
|
CAGR 5-Years
31%
|
CAGR 10-Years
13%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Current Portion of Long-Term Debt
$1.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
189%
|
CAGR 10-Years
68%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Accelerate Diagnostics Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
251k
USD
Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Current Portion of Long-Term Debt amounts to 251k USD.
What is Accelerate Diagnostics Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
10%
Over the last year, the Current Portion of Long-Term Debt growth was -87%. The average annual Current Portion of Long-Term Debt growth rates for Accelerate Diagnostics Inc have been -45% over the past three years , and 10% over the past ten years .
You don't have any saved screeners yet
